AS-012
N/A
Report date: 2022/11/27 23:59:02
NME
Base Information
Drug NameAS-012
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSun Pharma Global FZE
China Registration ClassN/A
Develop Information
Active CompaniesAche Laboratorios Farmaceuticos SaSun Pharma Global FZE
Inactive CompaniesSun Pharmaceutical Industries Ltd
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A